- Home
- PBFS vs LFCR Comparison
PBFS vs LFCR Comparison
Compare PBFS & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBFS | LFCR |
|---|---|---|
| Founded | 1889 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 333.8M | 269.8M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PBFS | LFCR |
|---|---|---|
| Price | $14.01 | $6.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 6.6K | ★ 115.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.67 | N/A |
| Revenue | $14,953,000.00 | ★ $557,559,000.00 |
| Revenue This Year | N/A | $2.80 |
| Revenue Next Year | N/A | $11.51 |
| P/E Ratio | $21.52 | ★ N/A |
| Revenue Growth | ★ 15.23 | 6.36 |
| 52 Week Low | $10.60 | $4.76 |
| 52 Week High | $15.18 | $8.98 |
Technical Indicators
Market Signals| Indicator | PBFS | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 43.08 | 36.07 |
| Support Level | $12.89 | $6.55 |
| Resistance Level | $14.08 | $7.03 |
| Average True Range (ATR) | 0.28 | 0.28 |
| MACD | -0.06 | -0.00 |
| Stochastic Oscillator | 8.25 | 39.76 |
Price Performance
Historical ComparisonAbout PBFS Pioneer Bancorp Inc.
Pioneer Bancorp Inc is involved in providing banking services. These services include Personal services such as Checking, Savings, eBanking Cards, and Business services such as Business Deposit and operating Accounts, Business eBanking, and Business loans. Some of the other services of the company include Government Banking, Wealth Management, Benefits Consulting and Insurance.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.